{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:53:46Z","timestamp":1788519226877,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ebiom.2024.105327","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T22:32:07Z","timestamp":1727994727000},"page":"105327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-2339","authenticated-orcid":false,"given":"Mar\u00eda","family":"Carmona-Iragui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Llibre-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105327_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105327_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-02988-7","article-title":"Revised criteria for the diagnosis and staging of Alzheimer's disease","author":"Jack","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib6","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","volume":"395","author":"Fortea","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105327_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer's disease associated with Down syndrome: a genetic form of dementia","volume":"20","author":"Fortea","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/alzrt213","article-title":"Dominantly Inherited Alzheimer Network: facilitating research and clinical trials","volume":"5","author":"Moulder","year":"2013","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.ebiom.2024.105327_bib9","article-title":"The Alzheimer's biomarker consortium-down syndrome: rationale and methodology","volume":"12","author":"Handen","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib10","first-page":"719","article-title":"Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain","volume":"39","author":"Alcolea","year":"2014","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib11","article-title":"Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease in subjects with Down syndrome","volume":"55","author":"Carmona-Iragui","year":"2017","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24319-x","article-title":"Phosphorylated tau 181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome","volume":"12","author":"Lle\u00f3","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(21)00129-0","article-title":"Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study","volume":"20","author":"Carmona-Iragui","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","article-title":"Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series","volume":"15","author":"Ryan","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in Down syndrome and the development of Alzheimer's disease neuropathology","volume":"13","author":"Head","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.ebiom.2024.105327_bib16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2024.105327_bib17","series-title":"Focusing on cellular biomarkers: the endo-lysosomal pathway in Down syndrom","first-page":"209","article-title":"e","author":"Bott\u00e9","year":"2020"},{"key":"10.1016\/j.ebiom.2024.105327_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","article-title":"The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome","volume":"6","author":"Davidson","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib19","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1093\/brain\/awaa326","article-title":"Evolution of neuroinflammation across the lifespan of individuals with Down syndrome","volume":"143","author":"Flores-Aguilar","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2024.105327_bib20","article-title":"Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome","volume":"12","author":"Martini","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbadis.2015.11.007","article-title":"Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome","volume":"1862","author":"Wilcock","year":"2016","journal-title":"Biochim Biophys Acta (BBA)\u2013Mol Basis Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib33","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105327_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(22)00408-2","article-title":"Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study","volume":"22","author":"Boerwinkle","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(24)00084-X","article-title":"Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study","volume":"23","author":"Wisch","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A\u00a0soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barth\u00e9lemy","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104547","article-title":"Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study","volume":"90","author":"Montoliu-Gaya","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2024.105327_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24319-x","article-title":"Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer\u2019s disease in adults with Down syndrome","volume":"12","author":"Lle\u00f3","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(20)30137-X","article-title":"Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study","volume":"19","author":"Quiroz","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib39","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/alz.12879","article-title":"Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: associations with A\u03b2-PET, neurodegeneration, and cognition","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105327_bib80","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/brain\/awac399","article-title":"Plasma biomarker profiles in autosomal dominant Alzheimer\u2019s disease","volume":"146","author":"Johansson","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2024.105327_bib23","article-title":"Challenges associated with biomarker-based classification systems for Alzheimer's disease","volume":"10","author":"Ill\u00e1n-Gala","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105327_bib24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib25","first-page":"4582","article-title":"The clinical and neuropathological features of sporadic (Late-Onset) and genetic forms of Alzheimer's disease","volume":"10","author":"Rujeedawa","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jalz.2018.12.019","article-title":"Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease","volume":"15","author":"Schindler","year":"2019","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib27","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awab166","article-title":"Plasma amyloid-\u03b2 ratios in autosomal dominant Alzheimer's disease: the influence of genotype","volume":"144","author":"O'Connor","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2024.105327_bib29","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1038\/s41380-020-0838-x","article-title":"Plasma phospho-tau 181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study","volume":"26","author":"O'Connor","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ebiom.2024.105327_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau 217 for alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105327_bib31","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/alz.12906","article-title":"Plasma p-tau 217 predicts in\u00a0vivo brain pathology and cognition in autosomal dominant Alzheimer's disease","volume":"19","author":"Aguillon","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib32","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau 231 and p-tau 217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23620-z","article-title":"A\u00a0multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0439-y","article-title":"Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease","volume":"10","author":"S\u00e1nchez-Valle","year":"2018","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.ebiom.2024.105327_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","article-title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study","volume":"21","author":"Morenas-Rodr\u00edguez","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12910","article-title":"Association of alzheimer disease with life expectancy in people with Down syndrome","volume":"5","author":"Iulita","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2024.105327_bib41","first-page":"1","article-title":"Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome","volume":"12","author":"Henson","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/dneu.22715","article-title":"Plasma amyloid and tau as dementia biomarkers in Down syndrome: systematic review and meta-analyses","volume":"79","author":"Alhajraf","year":"2019","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.ebiom.2024.105327_bib44","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(18)30285-0","article-title":"Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","volume":"17","author":"Fortea","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2022.1740","article-title":"Detection of brain tau pathology in Down syndrome using plasma biomarkers","volume":"79","author":"Janelidze","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-020-00398-0","article-title":"Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome","volume":"15","author":"Belbin","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ebiom.2024.105327_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3233\/JAD-2011-110197","article-title":"Investigating statistical epistasis in complex disorders","volume":"25","author":"Turton","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.1901166","article-title":"An altered relationship between soluble TREM2 and inflammatory markers in young adults with Down syndrome: a preliminary report","volume":"204","author":"Weber","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105327_bib50","first-page":"1143","article-title":"Erythromyeloid-derived TREM2: a major determinant of Alzheimer's disease pathology in Down syndrome","volume":"61","author":"Raha-Chowdhury","year":"2018","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib52","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/alz.12627","article-title":"Probing the proteome to explore potential correlates of increased Alzheimer\u2019s-related cerebrovascular disease in adults with Down syndrome","volume":"18","author":"Moni","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105327_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad280","article-title":"Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease","volume":"5","author":"Llibre-Guerra","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cortex.2015.07.032","article-title":"Behavioural and psychological symptoms of dementia in Down syndrome: early indicators of clinical Alzheimer's disease?","volume":"73","author":"Dekker","year":"2015","journal-title":"Cortex"},{"key":"10.1016\/j.ebiom.2024.105327_bib55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease \u2014 the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib56","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/alz.12552","article-title":"Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: baseline findings from the API ADAD Colombia Trial","volume":"18","author":"Vila-Castelar","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/alz.13460","article-title":"Investigation of sex differences in mutation carriers of the dominantly inherited Alzheimer network","volume":"20","author":"Wagemann","year":"2024","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad074","article-title":"Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome","volume":"5","author":"Iulita","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(21)00139-3","article-title":"Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study","volume":"20","author":"Fagan","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib60","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1093\/brain\/awac181","article-title":"Autosomal dominant and sporadic late onset Alzheimer's disease share a common in\u00a0vivo pathophysiology","volume":"145","author":"Morris","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2024.105327_bib61","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/alz.12505","article-title":"Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease","volume":"18","author":"Buckles","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105327_bib62","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/alz.12912","article-title":"Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease","volume":"19","author":"Xiong","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105327_bib63","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000507","article-title":"Disease duration in autosomal dominant familial Alzheimer disease","volume":"6","author":"Pavisic","year":"2020","journal-title":"Neurol Genet"},{"key":"10.1016\/j.ebiom.2024.105327_bib64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnen\/nlv028","article-title":"Neuropathology of autosomal dominant alzheimer disease in the national Alzheimer coordinating center database","volume":"75","author":"Ringman","year":"2016","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.ebiom.2024.105327_bib65","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jalz.2017.03.007","article-title":"Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease","volume":"13","author":"Carmona-Iragui","year":"2017","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ebiom.2024.105327_bib66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-160651","article-title":"Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"55","author":"Noguchi-Shinohara","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1326784","article-title":"Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications","volume":"18","author":"Doran","year":"2024","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ebiom.2024.105327_bib68","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/jcbfm.2015.25","article-title":"Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami","volume":"35","author":"Mart\u00ednez-Lizana","year":"2015","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.ebiom.2024.105327_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105327_bib70","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","article-title":"Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease","volume":"36","author":"Wilcock","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ebiom.2024.105327_bib71","first-page":"2776","article-title":"Epilepsy in Down syndrome: a highly prevalent comorbidity","volume":"10","author":"Altuna","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib72","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.5664\/jcsm.7382","article-title":"Prevalence of sleep disorders in adults with Down syndrome: a comparative study of self-reported, actigraphic, and polysomnographic findings","volume":"14","author":"Gim\u00e9nez","year":"2018","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108609","article-title":"On the relationships between epilepsy, sleep, and Alzheimer's disease: a narrative review","volume":"129","author":"Hanke","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebiom.2024.105327_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1684\/epd.2021.1406","article-title":"Epilepsy in neurodegenerative diseases","volume":"24","author":"Neri","year":"2022","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ebiom.2024.105327_bib75","first-page":"1091","article-title":"Misfolded \u03b1-synuclein in autosomal dominant Alzheimer's disease","volume":"97","author":"Fort-Aznar","year":"2024","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.ebiom.2024.105327_bib76","first-page":"3639","article-title":"Blood biomarkers for Alzheimer's disease in Down syndrome","volume":"10","author":"Montoliu-Gaya","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ebiom.2024.105327_bib77","first-page":"1","article-title":"Prevalence of aging, dementia, and multimorbidity in older adults with Down syndrome","author":"Bayen","year":"2018","journal-title":"JAMA Neurol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T12:44:06Z","timestamp":1729687446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":80,"alternative-id":["S2352396424003633"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105327","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105327"}}